Blackstone Inc’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.32M | Hold |
489,248
| – | – | 0.03% | 91 |
|
|
2025
Q1 | $7.89M | Buy |
489,248
+40,047
| +9% | +$646K | 0.03% | 83 |
|
|
2024
Q4 | $10.5M | Buy |
449,201
+156,206
| +53% | +$3.64M | 0.05% | 70 |
|
|
2024
Q3 | $8.62M | Hold |
292,995
| – | – | 0.04% | 76 |
|
|
2024
Q2 | $6.89M | Buy |
292,995
+273,004
| +1,366% | +$6.42M | 0.03% | 85 |
|
|
2024
Q1 | $758K | Hold |
19,991
| – | – | ﹤0.01% | 144 |
|
|
2023
Q4 | $430K | Buy |
+19,991
| New | +$430K | ﹤0.01% | 138 |
|